Daily Archives: July 4, 2019

Effects of Ustekinumab on Histologic Disease Activity in Patients with Crohn’s Disease

Posted on July 4, 2019 by Gastroenterology Journal

Although ustekinumab is an effective therapy for moderate to severe Crohn’s disease (CD), its effects on the microscopic manifestations of CD are unknown. Continue reading →

Posted in News | Comments Off on Effects of Ustekinumab on Histologic Disease Activity in Patients with Crohn’s Disease

Endoscopic, radiologic, and histologic healing with vedolizumab in patients with active Crohn’s disease

Posted on July 4, 2019 by Gastroenterology Journal

Vedolizumab is a gut-selective monoclonal antibody for the treatment of moderately to severely active Crohn’s disease (CD). We performed a prospective study of endoscopic, radiologic, and histologic healing in patients with CD who received vedolizuma… Continue reading →

Posted in News | Comments Off on Endoscopic, radiologic, and histologic healing with vedolizumab in patients with active Crohn’s disease

Sigmoid-derived neovaginal hemorrhage in a transgender patient

Posted on July 4, 2019 by Gastroenterology Journal
Posted in News | Comments Off on Sigmoid-derived neovaginal hemorrhage in a transgender patient